Neuro-ophthalmology of movement disorders

Current Opinion in Ophthalmology

Volumn 11, Issue 6, 2000, Pages 403-407

  Hamilton, Steven R ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLEPHAROSPASM; CEREBELLAR ATAXIA; CEREBELLUM DISEASE; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; EXTRAPYRAMIDAL SYNDROME; EYE MOVEMENT DISORDER; GILLES DE LA TOURETTE SYNDROME; HEMIFACIAL SPASM; HUMAN; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MUSCLE SPASM; NEUROOPHTHALMOLOGY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; VISION TEST; VISUAL IMPAIRMENT; VISUAL NERVOUS SYSTEM;

HUMANS; MOVEMENT DISORDERS; NEUROLOGY; OCULAR MOTILITY DISORDERS; OPHTHALMOLOGY; VISUAL PERCEPTION;

EID: 0033663202     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200012000-00004     Document Type: Article

References (50)

1. Control of voluntary and reflexive saccades in Parkinson's disease
2. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys
3. Remembered saccades with variable delay in Parkinson's disease
4. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation
5. Oculomotor abnormalities in diseases of the basal ganglia
6. Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson's disease
7. Visual and visual cognitive dysfunction in Parkinson's disease: Spatial and chromatic vision
8. Decreased color discrimination and contrast sensitivity in Parkinson's disease
9. Visual contrast response functions in Parkinson's disease: Evidence from electroretinograms, visual evoked potentials and psychophysics
10. Parvocellular and magnocellular visual processing in spinocerebellar degeneration and Parkinson's disease: An event-related potential study
11. Hallucinations in Parkinson's disease
12. Saccades and antisaccades in parkinsonian syndromes
13. Eye movement disorders in corticobasal degeneration
14. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes
15. Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross sectional study
16. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration
17. Neuropsychiatric features of corticobasal degeneration
18. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
19. Mutational analysis of the tau gene in progressive supranuclear palsy
20. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases
21. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17, and Pick's disease
22. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration, and Pick's disease
23. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple system atrophy compared with Parkinson's disease
24. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy
25. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy
26. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy
27. 2-weighted magnetic resonance imaging sequences: A specific marker of multiple system atrophy?
28. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
29. PET measures of benzodiazepine receptors in progressive supranuclear palsy
30. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy
31. Pharmacological therapy in progressive supranuclear palsy
32. Zolpidem in progressive supranuclear palsy
33. Longitudinal cognitive and motor changes among presymptomatic Huntington's disease gene carriers
34. Visually guided exploration in Huntington's disease
35. Oculomotor phenotypes in autosomal dominant ataxias
36. Autosomal dominant cerebellar ataxia: Phenotypic differences in genetically defined subtypes?
37. Vergence disorders in patients with spinocerebellar ataxia 3/Machada-Joseph disease: A synoptophore study
38. Autosomal dominant cerebellar ataxia type I: Oculomotor abnormalities in families with SCA1, SCA2, and SCA3
39. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees: The significance of slow saccades in diagnosis
40. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7)
41. Episodic ataxia and channelopathies
42. Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera
43. Idiopathic blepharospasm does not lead to a parkinsonian syndrome: Results of a questionnaire-based follow-up study
44. Impaired visual function in focal idiopathic dystonia
45. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias
46. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm
47. Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid
48. Hemifacial spasm: Clinical findings and treatment
49. Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette syndrome
50. Saccadic performance characteristics and the behavioral neurology of Tourette's syndrome